跳至主要内容
临床试验/NCT01578174
NCT01578174已完成不适用

The Effect of Dexmedetomidine in the Management of Pain After Uterine Artery Embolization

Severance Hospital1 个研究点 分布在 1 个国家目标入组 66 人开始时间: 2012年4月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
66
试验地点
1
主要终点
Fentanyl consumption by patient-controlled analgesia

研究概览

简要总结

The investigators examined the effect of dexmedetomidine in the management of pain after uterine artery embolization.

详细描述

Leiomyoma are the most common female reproductive tract tumors. Uterine artery embolization(UAE) is a minimally invasive treatment alternative to hysterectomy and myomectomy. However, post-procedural pain control after UAE remains a major problem. Therefore, the aim of study is to evaluate the efficacy of dexmedetomidine in pain control after UAE.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • age ≥ 20,
  • ASA class I and II

排除标准

  • bradycardia (< 45 bpm)
  • heart block
  • liver failure
  • renal failure
  • uncontrolled hypertension
  • body mass index ≥ 30 kg/m2

研究组 & 干预措施

Control

Placebo Comparator

干预措施: Normal saline 0.9% (Drug)

Dexmedetomidine

Active Comparator

干预措施: Dexmedetomidine (Drug)

结局指标

主要结局

Fentanyl consumption by patient-controlled analgesia

时间窗: 24 hours

次要结局

  • Side effects(24 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

So Yeon Kim

Clinical assistant professor

Severance Hospital

研究点 (1)

Loading locations...

相似试验

The Effect of Dexmedetomidine in the Management of... | 临床试验